A consortium of private equity investors composed of Apax Partners, Canada Pension Plan Investment Board (CPPIB) and Public Sector Pension Investment Board (PSP) has agreed to sell Acelity Inc. and its KCI subsidiaries to 3M at an enterprise value of approximately $6.7 billion. The EBITDA multiple for this transaction is shown below.
The three investors acquired Acelity through the November 2011 acquisition of publicly-traded Kinetic Concepts (KCI) $6.1 billion. The company was rebranded as Acelity in September 2014. The sale to 3M comes just two weeks after Acelity filed plans to go public for the third time in the company’s history.
Acelity designs, manufactures, markets and services therapies and products for the wound care and tissue regeneration markets. The company sells a range of products including KCI-branded negative pressure wound therapy, wound dressings, and negative pressure surgical incision management systems.
Acelity, led by CEO Andrew Eckert, has approximately 4,500 employees and is headquartered in San Antonio (www.acelity.com). Acelity had 2018 revenues of $1.5 billion. According to a statement from 3M, the enterprise value of this transaction equals 11x estimated annual adjusted EBITDA for the first 12 months following completion of the transaction, including expected run rate cost synergies.
During the ownership term, Apax, CPPIB and PSP worked with Acelity’s senior management team on organic growth strategies, including expansion of its sales force, and add-on acquisitions including the buy of UK-based Systagenix, a provider of wound care products, in July 2013; and the buy of Crawford Healthcare, also a provider of wound care products, in June 2018. In February 2017 the company sold its LifeCell business unit to Allergan for $2.9 billion and in November 2012 sold its Therapeutic Support Systems unit to Getinge AB for $275 million.
“We are proud of our close work with management to successfully transform KCI through a range of growth initiatives, including an M&A program, that enhanced the company’s strategic direction,” said Steven Dyson, chairman of the board of Acelity and a partner at Apax. “We believe the business will have a great future with 3M. Lastly, we are grateful for the opportunity to have joined in this highly successful investment with CPPIB and PSP, two long-standing investors in the Apax Funds.”
Leading the transaction CPPIB and PSP were Ryan Selwood, managing director and head of direct private equity at CPPIB, and Simon Marc, managing director and head of private equity at PSP.
At the closing of this transaction, expected in the second half of 2019, Acelity will become part of 3M’s Medical Solutions business which sells medical tapes, wound care dressings and products, sterilization products, and patient warming products.
“Acelity is a recognized leading provider of advanced wound care technologies and solutions and an excellent complement to our health care business,” said Mike Roman, 3M’s chief executive officer. “This acquisition bolsters our Medical Solutions business and supports our growth strategy to offer comprehensive advanced and surgical wound care solutions to improve outcomes and enhance the patient and provider experience.”
Apax invests in the technology and telecom; services; healthcare; and consumer sectors. The firm has seven offices located in London, New York, Munich, Tel Aviv, Mumbai, Hong Kong and Shanghai (www.apax.com).
The Canada Pension Plan Investment Board (CPPIB) invests in public equities, private equities, real estate, inflation-linked bonds, infrastructure and fixed income instruments. Net assets under management in December 2018 were C$368 billion. CPPIB is headquartered in Toronto, with offices in London, Hong Kong, New York, Hong Kong, Sydney, Sao Paulo, Mumbai, and Luxembourg (www.cppib.ca).
PSP Investments is one of Canada’s largest pension investment managers with C$159 billion of net assets under management in September 2018. PSP manages pension investments for the Federal Public Service, the Canadian Forces, the Royal Canadian Mounted Police and the Reserve Force and has offices in Montreal, New York, Hong Kong and London (www.investpsp.com).
JP Morgan and Goldman Sachs are the financial advisors to Apax, CPPIB and PSP, and Credit Suisse is the financial advisor to 3M.
3M will finance the buy of Acelity with a combination of available cash and proceeds from the issuance of new debt.
© 2019 Private Equity Professional | May 3, 2019